COVID Vaccine Preprint Study Prompts Twitter Outrage

News
890

Translate to Spanish or other 102 languages!

Image for illustration for Illustration purposes.

Medscape

- Advertisement -

A preprint study finding that the Pfizer-BioNTech mRNA COVID vaccine is associated with an increased risk for cardiac adverse events in teenage boys has elicited a firestorm on Twitter. 

Although some people issued thoughtful critiques, others lobbed insults against the authors, and still others accused them of either being anti-vaccine or stoking the fires of the vaccine skeptic movement.

For the complete story, click on the following link: https://www.medscape.com/viewarticle/958778?uac=209076CT&faf=1&sso=true&impID=3641968&src=mkm_covid_update_210915_MSCPEDIT

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
New FDA Records Show Purchases of Fetal Organs, Heads and Tissue for ‘Humanized Mice’ Project
Next article
Grand opening of HEAL Community Connection Center

More Articles

STHS Heart Earns National Recognition for Exceptional Stroke Care

Despite significant advances in prevention and treatment, cardiovascular disease remains the leading cause of death in the United States, accounting for nearly three in 10 deaths nationwide and claiming more than 940,000 lives each year, according to the Centers for Disease Control and Prevention (CDC).

Why Older Men Should Reconsider Their Long-Term Medications

One in three men will experience moderate-to-severe lower urinary tract symptoms in their lifetime, with symptoms including frequent urination, difficulty starting urination, nocturia and a weak urine stream. Although these are common symptoms, in older men, they can significantly impact quality of life.

STHS McAllen Recognized as National Leader in Stroke Care with 7th Consecutive Gold Plus Award

Stroke is the fifth-leading cause of death in the United States and one of the leading causes of serious long-term disability nationwide, according to the Stroke Awareness Foundation, affecting nearly 800,000 Americans each year.

Medicare’s New $50 GLP-1 Coverage: 7 Essential Facts to Know

For decades, it’s been against the law for Medicare to pay for weight-loss medication, but that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other reasons, access to some weight management medications if they meet certain weight and health criteria.
- Advertisement -